Market News & Trends
Ziarco Pharma Acquires Pfizer Drugs, Secures Financing
Ziarco recently announced the closing of an initial $6-million tranche of Series A financing totalling $27 million. The round was led by Biotechnology Value Fund…
11/14/2012
A Note to The Pharmaceutical Industry Upon The Re-Election of Barack Obama By: Matthew Herper, Forbes Staff, mherper@forbes.com I've covered the drug industry for 12…
10/30/2012
Arthritis Signifies a Vast Untouched Market, Finds Frost & Sullivan Tumor necrosis factor (TNF) inhibitors are currently the only therapeutic class available to psoriatic arthritis…
Arthritis Signifies a Vast Untouched Market, Finds Frost & Sullivan
Tumor necrosis factor (TNF) inhibitors are currently the only therapeutic class available to psoriatic arthritis (PsA) patients in need of additional therapy beyond standard of…
Bayer & QIAGEN Partner on Cancer Companion Dx
QIAGEN and Bayer HealthCare recently announced a collaboration agreement for the development and commercialization of companion diagnostics paired with novel Bayer HealthCare drugs, initially to…
DSM Announces Biologics Development & Manufacturing Agreement
DSM Pharmaceutical Products recently announced it has signed a biologics contract manufacturing agreement with Paranta Biosciences Ltd of Melbourne, Australia. The contract covers the process…
Fuisz Pharma Announces Patented Film Formulations
Fuisz Pharma recently announced a patented film formulation for enhanced drug delivery performance. The seminal patent for this technology issued as United States Patent No.…
Novozymes & Malvern Publish Collaborative Study
In a recently published article, researchers from Novozymes Biopharma and Malvern Instruments describe collaborative work using light scattering techniques to demonstrate the short- and long-term…
Shire Invests $22 Million Into R&D Partnership
Shire plc recently announced a long-term, broad-based, multi-indication research collaboration in rare diseases with Fondazione Telethon, a major Italian biomedical charitable foundation, for research carried…
EMD Millipore Announces Partnership With NIH Consortium
EMD Millipore, the Life Science division of Merck KGaA of Darmstadt, Germany, recently announced it has entered into an agreement with an academic consortium funded…
Foster Reports Increased Interest in Implantable Applications
Foster Corporation, a leader in custom medical polymers, recently reported increased interest in implantable medical device applications by polymer suppliers. While risk mitigation remains a…
Theravance & Merck Sign Major Cardiovascular Collaboration
Theravance, Inc.recently announced it has signed a collaboration agreement with Merck, known as MSD outside the United States and Canada, to discover, develop, and commercialize…
Unilife Develops Breakthrough Device Technologies
Unilife Corporationrecently announced the development of two new breakthrough platform technologies for targeted drug delivery that can enable and enhance patient outcomes for many acute…
10/24/2012
Avantor & Rubicon to Collaborate on Next-Generation Functional Excipients Avantor Performance Materials recently announced it has signed a collaboration agreement with Rubicon Research Private…
Avantor & Rubicon to Collaborate on Next-Generation Functional Excipients
Avantor Performance Materials recently announced it has signed a collaboration agreement with Rubicon Research Private LTD of Mumbai, aimed at combining the Indian company's proprietary…
Catalent Announces Drug Delivery Institute
Catalent Pharma Solutions recently announced the launch of its Catalent Applied Drug Delivery Institute at the 2012 American Association of Pharmaceutical Scientists (AAPS) Annual Meeting…
10/16/2012
Catalent Licenses Innovative Technology Following a successful research collaboration, Catalent Pharma Solutions recently announced it has taken an exclusive license to innovative taste-masking technology developed…
Aptalis Sponsors AAPS Research Achievement Awards
Aptalis Pharmaceutical Technologies, formerly Eurand, focused on developing differentiated oral products utilizing its pharmaceutical technologies, recently announced its sponsorship of the American Association of Pharmaceutical…
Bend Research Receives US Patents for Technology to Enhance Bioavailability
Bend Research Inc. recently announced it has received two new US patents related to its pioneering efforts to improve the oral bioavailability of low-solubility drugs.…
Catalent Licenses Innovative Technology
Following a successful research collaboration, Catalent Pharma Solutions recently announced it has taken an exclusive license to innovative taste-masking technology developed by the New…